-
(WG, MHS, ESRX, EXXI, ANN) Price Targets Changed at UBS
Monday, November 22, 2010 - 12:23pm | 81UBS has changed its price target on the following companies: Willbros Group (NYSE: WG) from $9.10 to $7.75. Medco Health Solutions (NYSE: MHS) from $70 to $76. Express Scripts (NASDAQ: ESRX) from $63 to $66. Energy XXI (NASDAQ: EXXI) from $26 to $34. Ann Taylor (NYSE: ANN) from $30 to $32.
-
J.P. Morgan Sees Significant Upside In Medco Health Solutions (MHS)
Monday, November 22, 2010 - 8:19am | 133J.P. Morgan Chase & Co. sees significant upside in shares of Medco Health Solutions, Inc. (NYSE: MHS), as it has a $78 price target on shares, nearly 30% higher than where shares are currently trading. It has an Overweight rating on shares. In a note sent to investors, J.P. Morgan writes, "We...
-
Electronic Components should Power growth at CTS Corp. (CTS) - Analyst Blog
Friday, November 19, 2010 - 4:00pm | 461CTS Corporation ( CTS ) designs, manufactures, assembles, and sells a broad line of electronic components and sensors. The firm also provides electronics manufacturing services primarily to original equipment manufacturers (OEMs), for the automotive, computer, communications, medical, industrial...
-
LabCorp Clears Anti-Trust Review - Analyst Blog
Friday, November 19, 2010 - 3:33pm | 493Laboratory Corporation of America Holdings (LH) moves a step closer in the process of acquiring Genzyme Genetics, a unit of Genzyme Corporation (GENZ). Recently, LabCorp received clearance from the Federal Trade Commission for the acquisition. Earlier, in September, LabCorp had announced its...
-
GENZ in Deal for Sale of Diag Biz - Analyst Blog
Friday, November 19, 2010 - 2:00pm | 455Genzyme Corporation (GENZ) recently announced that it has entered into an agreement with Japanese company, Sekisui Chemical Co., Ltd. for the sale of its diagnostic products business. Sekisui will acquire Genzyme's diagnostic products business for $265 million cash. The diagnostics business...
-
Air Methods Corporation Up 3% (AIRM )
Friday, November 19, 2010 - 12:02pm | 76Air Methods Corporation (NASDAQ: AIRM) is up 3% on heavy volume today. The company has already traded more than 100,000 shares, which is the company's daily volume. At last check, shares of AIRM were up $1.70 to $46.26, a gain of 3.8%. Air Methods Corporation provides air medical emergency...
-
Electronic Components should Power growth at CTS Corp. (CTS) - Analyst Blog
Friday, November 19, 2010 - 10:30am | 461CTS Corporation ( CTS ) designs, manufactures, assembles, and sells a broad line of electronic components and sensors. The firm also provides electronics manufacturing services primarily to original equipment manufacturers (OEMs), for the automotive, computer, communications, medical, industrial...
-
LabCorp Clears Anti-Trust Review - Analyst Blog
Friday, November 19, 2010 - 10:20am | 493Laboratory Corporation of America Holdings (LH) moves a step closer in the process of acquiring Genzyme Genetics, a unit of Genzyme Corporation (GENZ). Recently, LabCorp received clearance from the Federal Trade Commission for the acquisition. Earlier, in September, LabCorp had announced its...
-
IPC The Hospitalist Company Acquires Practice in Michigan
Friday, November 19, 2010 - 9:31am | 61IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) announced today that it has acquired the hospitalist practice of Hospitalists of West Michigan, PC headquartered in Grand Rapids, Michigan. The acquisition represents a further expansion in the Michigan market, where IPC already has a well-...
-
GENZ in Deal for Sale of Diag Biz - Analyst Blog
Friday, November 19, 2010 - 8:30am | 455Genzyme Corporation (GENZ) recently announced that it has entered into an agreement with Japanese company, Sekisui Chemical Co., Ltd. for the sale of its diagnostic products business. Sekisui will acquire Genzyme's diagnostic products business for $265 million cash. The diagnostics business...
-
Emergency Medical Remains Neutral - Analyst Blog
Thursday, November 18, 2010 - 7:03pm | 493We recently reiterated our Neutral recommendation on Emergency Medical (EMS), a leading provider of emergency medical services in the US. During the third quarter of fiscal 2010, Emergency Medical reported an EPS of $0.82, up 24.7% from $0.66 in the year-ago period. However, the EPS missed the...
-
Aflac Upped to Outperform - Analyst Blog
Thursday, November 18, 2010 - 4:03pm | 682On Thursday, we upgraded our recommendation on the shares of Aflac Inc. (AFL) to Outperform from Neutral based on its recent dividend hike coupled with the resumption of its stock buyback program, reflecting a fair liquidity and retaining investors' confidence. Besides, Aflac's third quarter...
-
Emergency Medical Remains Neutral - Analyst Blog
Thursday, November 18, 2010 - 1:18pm | 493We recently reiterated our Neutral recommendation on Emergency Medical (EMS), a leading provider of emergency medical services in the US. During the third quarter of fiscal 2010, Emergency Medical reported an EPS of $0.82, up 24.7% from $0.66 in the year-ago period. However, the EPS missed the...
-
LabCorp's Genzyme Genetics Acquisition Clears Antitrust Review
Thursday, November 18, 2010 - 12:00pm | 97Laboratory Corporation of America Holdings (NYSE: LH) today announced that it has received early termination from the Federal Trade Commission of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, applicable to the acquisition of Genzyme Genetics, a...
-
Zacks Sell List Highlights: True Religion Apparel, Crucell N.V. (ADR), Liz Claiborne, Inc. and Quest Diagnostics Inc - Press Releases
Thursday, November 18, 2010 - 11:36am | 2084For Immediate Release Chicago, IL – November 18, 2010 – Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List – Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 (Strong Sell): True Religion Apparel, Inc. (TRLG) and...